$2.48T
Total marketcap
$66.33B
Total volume
BTC 50.30%     ETH 16.00%
Dominance

Concert Pharmaceuticals CNCE Stock

8.37 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
0 USD
LOW - HIGH [24H]
8.35 - 8.55 USD
VOLUME [24H]
10.73M USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Concert Pharmaceuticals Price Chart

Concert Pharmaceuticals CNCE Financial and Trading Overview

Concert Pharmaceuticals stock price 8.37 USD
Previous Close 8.37 USD
Open 8.38 USD
Bid 0 USD x 1800
Ask 0 USD x 21500
Day's Range 8.35 - 8.55 USD
52 Week Range 2.72 - 8.55 USD
Volume 0 USD
Avg. Volume 2.64M USD
Market Cap 401.95M USD
Beta (5Y Monthly) 0.520519
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 13 USD

CNCE Valuation Measures

Enterprise Value 265.92M USD
Trailing P/E N/A
Forward P/E -3.111524
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 12.544446
Price/Book (mrq) 3.0107913
Enterprise Value/Revenue 8.299
Enterprise Value/EBITDA -2.922

Trading Information

Concert Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.520519
52-Week Change 116.27%
S&P500 52-Week Change -1.50%
52 Week High 8.55 USD
52 Week Low 2.72 USD
50-Day Moving Average 7.68 USD
200-Day Moving Average 6.05 USD

CNCE Share Statistics

Avg. Volume (3 month) 2.64M USD
Avg. Daily Volume (10-Days) 2.51M USD
Shares Outstanding 48.02M
Float 43.66M
Short Ratio 0.26
% Held by Insiders 3.77%
% Held by Institutions 77.05%
Shares Short 1.08M
Short % of Float 2.43%
Short % of Shares Outstanding 2.23%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) September 30, 2022
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin 0%
Operating Margin (ttm) -287.96%
Gross Margin -220.52%
EBITDA Margin -284.011%

Management Effectiveness

Return on Assets (ttm) -38.52%
Return on Equity (ttm) -108.68%

Income Statement

Revenue (ttm) 32.04M USD
Revenue Per Share (ttm) 0.79 USD
Quarterly Revenue Growth (yoy) -98.50%
Gross Profit (ttm) -54977000 USD
EBITDA -91003000 USD
Net Income Avi to Common (ttm) -126682000 USD
Diluted EPS (ttm) -3.17
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 149.53M USD
Total Cash Per Share (mrq) 3.12 USD
Total Debt (mrq) 14.21M USD
Total Debt/Equity (mrq) 10.67 USD
Current Ratio (mrq) 9.035
Book Value Per Share (mrq) 2.78

Cash Flow Statement

Operating Cash Flow (ttm) -109663000 USD
Levered Free Cash Flow (ttm) -43797752 USD

Profile of Concert Pharmaceuticals

Country United States
State MA
City Lexington
Address 65 Hayden Avenue
ZIP 02421
Phone 781 860 0045
Website https://www.concertpharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 64

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of March 6, 2023, Concert Pharmaceuticals, Inc. operates as a subsidiary of Sun Pharmaceutical Industries Limited.

Q&A For Concert Pharmaceuticals Stock

What is a current CNCE stock price?

Concert Pharmaceuticals CNCE stock price today per share is 8.37 USD.

How to purchase Concert Pharmaceuticals stock?

You can buy CNCE shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Concert Pharmaceuticals?

The stock symbol or ticker of Concert Pharmaceuticals is CNCE.

Which industry does the Concert Pharmaceuticals company belong to?

The Concert Pharmaceuticals industry is Biotechnology.

How many shares does Concert Pharmaceuticals have in circulation?

The max supply of Concert Pharmaceuticals shares is 0.

What is Concert Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Concert Pharmaceuticals PE Ratio is now.

What was Concert Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Concert Pharmaceuticals EPS is 0 USD over the trailing 12 months.

Which sector does the Concert Pharmaceuticals company belong to?

The Concert Pharmaceuticals sector is Healthcare.

Concert Pharmaceuticals CNCE included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16175.09 USD
-1.62
3.94B USD 16125.33 USD 16341.46 USD 3.94B USD
NASDAQ Composite Total Return I XCMP 19659.36 USD
-1.62
19598.88 USD 19861.56 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Biotechnology Total Retu XNBI 4501.69 USD
-2.14
4479.13 USD 4578.05 USD
NASDAQ Global Market Composite NQGM 2160.36 USD
-2.45
2147.48 USD 2200.33 USD
NASDAQ Biotechnology NBI 4195.13 USD
-2.14
4174.1 USD 4266.29 USD
NASDAQ HealthCare IXHC 958.68 USD
-2.07
954.08 USD 972.42 USD

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap